News

The results show an impressive 63% objective response rate (ORR) in 43 evaluable patients in a phase 2 trial, as of a 27th ...
Beghou Consulting hires new CEO, AI expert. Beghou Consulting, an Evanston, Illinois-based consultancy firm supporting life ...
Sanofi has been given a reprimand by the UK's Prescription Medicines Code of Practice Authority (PMCPA), after admitting that ...
Autolus' CAR-T cell therapy for a rare and aggressive form of acute lymphoblastic leukaemia (ALL), Aucatzyl, has been ...
Artificial intelligence (AI) and other innovations in data science are making these advances possible – but at this point, ...
The internationally renowned cancer centre is working on the project – billed as the UK's first large-scale, AI-powered radiology platform for cancer research – with digital transformation specialist ...
The field of 3D bioprinting technology is witnessing rapid advancements, offering new possibilities in regenerative medicine, tissue engineering, and pharmaceutical research. Some of the trends that ...
Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...